Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Net Asset Value(s)

28 Oct 2021 07:00

VanEck Vectors ETF's N.V. - Net Asset Value(s)

VanEck Vectors ETF's N.V. - Net Asset Value(s)

PR Newswire

London, October 27

Fund NameNAV DateTicker SymbolISINShares in IssueNet Asset ValueNAV per Share
VANECK AEX UCITS ETF 2021-10-27NL00092727492990000.000244208550.0281.6751
VANECK AMX UCITS ETF2021-10-27NL0009272756261000.00027886006.59106.8429
VANECK MULTI-ASSET BALANCED2021-10-27NL0009272772413000.00029003479.3970.2263
VANECK MULTI-ASSET GROWTH ALLO2021-10-27NL0009272780320000.00024740406.6777.3138
VANECK GLOBAL REAL ESTATE2021-10-27NL000969023910285404.000450012810.4643.7526
VANECK IBOXX EUR CORPORATES2021-10-27NL00096902473368390.00062601315.9318.5849
VANECK IBOXX EUR SOV DIV 1-102021-10-27NL00096902543276537.00047096683.2914.3739
VANECK IBOXX EUR AAA-AA 1-52021-10-27NL00102738019181000.000189709486.5020.6633
VANECK EUR EQUAL WEIGHT UCITS 2021-10-27NL0010731816730000.00049521208.8367.8373
VANECK MORN N-AMERICA EQUAL2021-10-27NL0011376074215255.00010168079.9447.2374
VANECK MORN DM DIV LEADERS2021-10-27NL00116835941800000.00052414170.5229.1190
VANECK SUS WORLD EQUAL WEIGHT2021-10-27NL001040870416503010.000479560080.3029.0589
VANECK MULTI-ASSET CONSERVAT 2021-10-27NL0009272764338000.00021350460.9863.1670

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.